N
Nancy Houston-Miller
Researcher at Stanford University
Publications - 29
Citations - 4696
Nancy Houston-Miller is an academic researcher from Stanford University. The author has contributed to research in topics: Risk factor & Randomized controlled trial. The author has an hindex of 21, co-authored 29 publications receiving 4404 citations. Previous affiliations of Nancy Houston-Miller include Harvard University & Durham University.
Papers
More filters
Journal ArticleDOI
Interventions to Promote Physical Activity and Dietary Lifestyle Changes for Cardiovascular Risk Factor Reduction in Adults A Scientific Statement From the American Heart Association
Nancy T. Artinian,Gerald F. Fletcher,Dariush Mozaffarian,Penny M. Kris-Etherton,Linda Van Horn,Alice H. Lichtenstein,Shiriki K. Kumanyika,William E. Kraus,Jerome L. Fleg,Nancy S. Redeker,Janet C. Meininger,JoAnne Banks,Eileen M. Stuart-Shor,Barbara J. Fletcher,Todd D. Miller,Suzanne Hughes,Lynne T. Braun,Laurie A. Kopin,Kathy Berra,Laura L. Hayman,Linda J. Ewing,Philip A. Ades,J. Larry Durstine,Nancy Houston-Miller,Lora E. Burke +24 more
TL;DR: In order to achieve these goals, healthcare providers must focus on reducing CVD risk factors such as overweight and obesity, which could increase by almost 7 years if all forms of major CVD were eliminated.
Journal ArticleDOI
Primary Prevention of Coronary Heart Disease: Guidance From Framingham: A Statement for Healthcare Professionals From the AHA Task Force on Risk Reduction
Scott M. Grundy,Gary J. Balady,Michael H. Criqui,Gerald F. Fletcher,Philip Greenland,Loren F. Hiratzka,Nancy Houston-Miller,Penny M. Kris-Etherton,Harlan M. Krumholz,John C. LaRosa,Ira S. Ockene,Thomas A. Pearson,James Reed,Reginald L. Washington,Sidney C. Smith +14 more
TL;DR: The Framingham Heart Study has contributed importantly to understanding of the causes of coronary heart disease (CHD), stroke, and other cardiovascular diseases as mentioned in this paper, and the NCEP guidelines adjust the intensity of cholesterol-lowering therapy with absolute risk as determined by summation of risk factors.
Journal ArticleDOI
Smoking cessation after acute myocardial infarction: effects of a nurse-managed intervention.
TL;DR: A nurse-managed smoking cessation intervention largely conducted by telephone, initiated in the hospital, and focused on relapse prevention can significantly reduce smoking rates at 12 months in patients who have had a myocardial infarction.
Journal ArticleDOI
Effect of Natriuretic Peptide-Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.
G. Michael Felker,Kevin J. Anstrom,Kirkwood F. Adams,Justin A. Ezekowitz,Mona Fiuzat,Nancy Houston-Miller,James L. Januzzi,Daniel B. Mark,Ileana L. Piña,Gayle Passmore,David J. Whellan,Hongqiu Yang,Lawton S. Cooper,Eric S. Leifer,Patrice Desvigne-Nickens,Christopher M. O'Connor +15 more
TL;DR: In high-risk patients with HFrEF, a strategy of NT-proBNP–guided therapy was not more effective than a usual care strategy in improving outcomes.
Journal ArticleDOI
Preventing heart attack and death in patients with coronary disease
Sidney C. Smith,Steven N. Blair,Michael H. Criqui,Gerald F. Fletcher,Valentin Fuster,Bernard J. Gersh,Antonio M. Gotto,K. Lance Gould,Philip Greenland,Scott M. Grundy,Martha N. Hill,Mark A. Hlatky,Nancy Houston-Miller,Ronald M. Krauss,John C. LaRosa,Ira S. Ockene,Suzanne Oparil,Thomas A. Pearson,Elliot Rapaport,Rodman D. Starke +19 more